Comparison of the Efficacy of Melatonin and 1400W on Renal Ischemia/Reperfusion Injury: A Role for Inhibiting iNOS

REFERENCES

• Sheridan AM, Bonventre JV. Pathophysiology of ischemic acute renal failure. Contrib Nephrol. 2001;7–21.
   PubMed Web of Science ®Google Scholar
• Rondon-Berrios H, Palevsky PM. Treatment of acute kidney injury: An update on the management of renal replacement therapy. Curr Opin Nephrol Hypertens. 2007;16:64–70.
   PubMed Web of Science ®Google Scholar
• Chatterjee PK. Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: A comprehensive review. Naunyn Schmiedebergs Arch Pharmacol. 2007;376:1–43.
   PubMed Web of Science ®Google Scholar
• Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med. 2000;109:665–678.
   PubMed Web of Science ®Google Scholar
• Guven A, Tunc T, Topal T, Alpha-lipoic acid and ebselen prevent ischemia/reperfusion injury in the rat intestine. Surg Today. 2008;38:1029–1035.
   PubMed Web of Science ®Google Scholar
• Mallick IH, Yang W, Winslet MC, Seifalian AM. Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci. 2004;49:1359–1377.
   PubMed Web of Science ®Google Scholar
• Li C, Jackson RM. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol. 2002;282:C227–C241.
   PubMed Web of Science ®Google Scholar
• Greene EL, Paller MS. Oxygen free radicals in acute renal failure. Miner Electrolyte Metab. 1991;17:124–132.
   PubMedGoogle Scholar
• Weidig P, McMaster D, Bayraktutan U. High glucose mediates pro-oxidant and antioxidant enzyme activities in coronary endothelial cells. Diabetes Obes Metab. 2004;6:432–441.
   PubMed Web of Science ®Google Scholar
• Cooke CL, Davidge ST. Peroxynitrite increases iNOS through NF-kappaB and decreases prostacyclin synthase in endothelial cells. Am J Physiol Cell Physiol. 2002;282:C395–C402.
   PubMed Web of Science ®Google Scholar
• Stockklauser-Farber K, Ballhausen T, Laufer A, Rosen P. Influence of diabetes on cardiac nitric oxide synthase expression and activity. Biochim Biophys Acta. 2000;1535:10–20.
   PubMedGoogle Scholar
• Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109–142.
   PubMed Web of Science ®Google Scholar
• Guven A, Uysal B, Akgul O, Scavenging of peroxynitrite reduces renal ischemia/reperfusion injury. Ren Fail. 2008;30:747–754.
   PubMed Web of Science ®Google Scholar
• Korkmaz A, Topal T, Oter S, Tan DX, Reiter RJ. Hyperglycemia-related pathophysiologic mechanisms and potential beneficial actions of melatonin. Mini Rev Med Chem. 2008;8:1144–1153.
   PubMedGoogle Scholar
• Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol. 1996;271:C1424–C1437.
   PubMed Web of Science ®Google Scholar
• Messina A, Knight KR, Dowsing BJ, Localization of inducible nitric oxide synthase to mast cells during ischemia/reperfusion injury of skeletal muscle. Lab Invest. 2000;80:423–431.
   PubMed Web of Science ®Google Scholar
• Takimoto Y, Aoyama T, Keyamura R, Differential expression of three types of nitric oxide synthase in both infarcted and non-infarcted left ventricles after myocardial infarction in the rat. Int J Cardiol. 2000;76:135–145.
   PubMedGoogle Scholar
• Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci. 1997;17:9157–9164.
   PubMed Web of Science ®Google Scholar
• Isobe M, Katsuramaki T, Kimura H, Role of inducible nitric oxide synthase on hepatic ischemia and reperfusion injury. Transplant Proc. 2000;32:1650–1652.
   PubMedGoogle Scholar
• Ling H, Edelstein C, Gengaro P, Attenuation of renal ischemia-reperfusion injury in inducible nitric oxide synthase knockout mice. Am J Physiol. 1999;277:F383–F390.
   Google Scholar
• Yanarates O, Guven A, Sizlan A, Ameliorative effects of proanthocyanidin on renal ischemia/reperfusion injury. Ren Fail. 2008;30:931–938.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX. Melatonin: A novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res. 2003;58:10–19.
   PubMed Web of Science ®Google Scholar
• Sahna E, Parlakpinar H, Ozturk F, Cigremis Y, Acet A. The protective effects of physiological and pharmacological concentrations of melatonin on renal ischemia-reperfusion injury in rats. Urol Res. 2003;31:188–193.
   PubMedGoogle Scholar
• Sahna E, Parlakpinar H, Turkoz Y, Acet A. Protective effects of melatonin on myocardial ischemia/reperfusion induced infarct size and oxidative changes. Physiol Res. 2005;54:491–495.
   PubMed Web of Science ®Google Scholar
• Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ. One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species?. J Pineal Res. 2007;42:28–42.
   PubMed Web of Science ®Google Scholar
• Peyrot F, Ducrocq C. Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species. J Pineal Res. 2008;45:235–246.
   PubMed Web of Science ®Google Scholar
• Mark LA, Robinson AV, Schulak JA. Inhibition of nitric oxide synthase reduces renal ischemia/reperfusion injury. J Surg Res. 2005;129:236–241.
   PubMed Web of Science ®Google Scholar
• Ovechkin AV, Lominadze D, Sedoris KC, Inhibition of inducible nitric oxide synthase attenuates platelet adhesion in subpleural arterioles caused by lung ischemia-reperfusion in rabbits. J Appl Physiol. 2005;99:2423–2432.
   PubMed Web of Science ®Google Scholar
• Chatterjee PK, Patel NS, Kvale EO, Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int. 2002;61:862–871.
   PubMed Web of Science ®Google Scholar
• Yanarates O, Guven A, Sizlan A, Ameliorative effects of proanthocyanidin on renal ischemia/reperfusion injury. Ren Fail. 2008;30:931–938.
   PubMed Web of Science ®Google Scholar
• Rabb H, Ramirez G, Saba SR, Renal ischemic-reperfusion injury in L-selectin-deficient mice. Am J Physiol. 1996;271:F408–F413.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Jou MJ, Biogenic amines in the reduction of oxidative stress: Melatonin and its metabolites. Neuro Endocrinol Lett. 2008;29:391–398.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Osuna C, Gitto E. Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci. 2000;7:444–458.
   PubMed Web of Science ®Google Scholar
• Ceraulo L, Ferrugia M, Tesoriere L, Interactions of melatonin with membrane models: Portioning of melatonin in AOT and lecithin reversed micelles. J Pineal Res. 1999;26:108–112.
   PubMed Web of Science ®Google Scholar
• Rodriguez C, Mayo JC, Sainz RM, Regulation of antioxidant enzymes: A significant role for melatonin. J Pineal Res. 2004;36:1–9.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Maldonado MD. Melatonin as an antioxidant: Physiology versus pharmacology. J Pineal Res. 2005;39:215–216.
   PubMed Web of Science ®Google Scholar
• Winiarska K, Fraczyk T, Malinska D, Drozak J, Bryla J. Melatonin attenuates diabetes-induced oxidative stress in rabbits. J Pineal Res. 2006;40:168–176.
   PubMed Web of Science ®Google Scholar
• Lin WY, Levin RM, Chichester P, Effects of L‐arginine and L-NAME on chronic partial bladder outlet obstruction in rabbit. Am J Physiol Regul Integr Comp Physiol. 2007;293:R2390–R2399.
   Google Scholar
• Tunc T, Uysal B, Atabek C, Erdosteine and ebselen as useful agents in intestinal ischemia/reperfusion injury. J Surg Res. 2008;155(2):210–216.
   PubMedGoogle Scholar
• Oztas E, Guven A, Turk E, 3-aminobenzamide, a poly ADP ribose polymerase inhibitor, attenuates renal ischemia/reperfusion injury. Ren Fail. 2009;31(5):393–399.
   PubMed Web of Science ®Google Scholar
• Guven A, Gundogdu G, Uysal B, Hyperbaric oxygen therapy reduces the severity of necrotizing enterocolitis in a neonatal rat model. J Pediatr Surg. 2009;44:534–540.
   PubMed Web of Science ®Google Scholar
• Korkmaz A, Reiter RJ, Topal T, Melatonin: An established antioxidant worthy of use in clinical trials. Mol Med. 2009;15:43–50.
   PubMed Web of Science ®Google Scholar